1. Microbiological profile of diabetic foot infections in China and worldwide: a 20-year systematic review.
- Author
-
Yu-dun Qu, Shuan-ji Ou, Wei Zhang, Jia-xuan Li, Chang-liang Xia, Yang Yang, Jia-bao Liu, Yun-fei Ma, Nan Jiang, Ye-yang Wang, Bo Chen, Bin Yu, Yong Qi, and Chang-peng Xu
- Subjects
DIABETIC foot ,GRAM-negative aerobic bacteria ,PATHOGENIC bacteria ,AEROBIC bacteria ,GRAM-negative bacteria ,ENTEROCOCCUS - Abstract
Introduction: Pathogens causing diabetic foot infections (DFIs) vary by region globally; however, knowledge of the causative organism is essential for effective empirical treatment. We aimed to determine the incidence and antibiotic susceptibility of DFI pathogens worldwide, focusing on Asia and China. Methods: Through a comprehensive literature search, we identified published studies on organisms isolated from DFI wounds from January 2000 to December 2020. Results: Based on our inclusion criteria, we analyzed 245 studies that cumulatively reported 38,744 patients and 41,427 isolated microorganisms. DFI pathogens varied according totime and region. Over time, the incidence of Gram-positive andGramnegative aerobic bacteria have decreased and increased, respectively. America and Asia have the highest (62.74%) and lowest (44.82%) incidence of Gram-negative bacteria, respectively. Africa has the highest incidence (26.90%) of methicillinresistant Staphylococcus aureus. Asia has the highest incidence (49.36%) of Gram-negative aerobic bacteria with species infection rates as follows: Escherichia coli, 10.77%; Enterobacter spp., 3.95%; and Pseudomonas aeruginosa, 11.08%, with higher local rates in China and Southeast Asia. Linezolid, vancomycin, and teicoplanin were the most active agents against Gram-positive aerobes, while imipenemandcefoperazone-sulbactamwerethemostactiveagentsagainstGramnegative aerobes. Discussion: This systematic review showed that over 20 years, the pathogens causing DFIs varied considerably over time and region. This data may inform local clinical guidelines on empirical antibiotic therapy for DFI in China and globally. Regular large-scale epidemiological studies are necessary to identify trends in DFI pathogenic bacteria. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF